We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+23.43%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$16.4B
AUM Growth
-$5.58B
Cap. Flow
-$3.87B
Cap. Flow %
-23.65%
Top 10 Hldgs %
18.07%
Holding
3,458
New
283
Increased
974
Reduced
1,077
Closed
907

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$114M
2
BMY icon
Bristol-Myers Squibb
BMY
+$109M
3
TT icon
Trane Technologies
TT
+$106M
4
MSFT icon
Microsoft
MSFT
+$104M
5
MA icon
Mastercard
MA
+$104M

Sector Composition

Rank Sector Weight
1 Technology 23.03%
2 Healthcare 13.89%
3 Financials 11.27%
4 Consumer Discretionary 8.92%
5 Industrials 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RRC icon
1801
Range Resources
RRC
$9.24B
$12K ﹤0.01%
2,241
-392
-15% -$2.17K
SBCF icon
1802
Seacoast Banking Corp of Florida
SBCF
$3.35B
$12K ﹤0.01%
619
+28
+5% +$569
SCHA icon
1803
Schwab U.S Small- Cap ETF
SCHA
$22.3B
$12K ﹤0.01%
776
-2,752
-78% -$41.2K
WLY icon
1804
John Wiley & Sons Class A
WLY
$2.66B
$12K ﹤0.01%
+323
New +$12.3K
CSII
1805
DELISTED
Cardiovascular Systems, Inc.
CSII
$12K ﹤0.01%
396
+98
+33% +$3.66K
JOBS
1806
DELISTED
51job Inc
JOBS
$12K ﹤0.01%
+176
New +$11.5K
TGP
1807
DELISTED
Teekay LNG Partners L.P.
TGP
$12K ﹤0.01%
1,113
ETFC
1808
DELISTED
E*Trade Financial Corporation
ETFC
$12K ﹤0.01%
+251
New +$10.8K
CBB
1809
DELISTED
Cincinnati Bell Inc.
CBB
$12K ﹤0.01%
834
+370
+80% +$5.46K
CEO
1810
DELISTED
CNOOC Limited
CEO
$12K ﹤0.01%
113
-20
-15% -$2.26K
ANIK icon
1811
Anika Therapeutics
ANIK
$240M
$11K ﹤0.01%
296
+147
+99% +$4.84K
ATKR icon
1812
Atkore
ATKR
$2.4B
$11K ﹤0.01%
412
+54
+15% +$1.34K
BBWI icon
1813
Bath & Body Works
BBWI
$4.02B
$11K ﹤0.01%
935
+39
+4% +$435
BHE icon
1814
Benchmark Electronics
BHE
$2.85B
$11K ﹤0.01%
554
+40
+8% +$838
BIO icon
1815
Bio-Rad Laboratories Class A
BIO
$8.74B
$11K ﹤0.01%
27
-2,373
-99% -$1.05M
BKH icon
1816
Black Hills Corp
BKH
$5.5B
$11K ﹤0.01%
196
-10
-5% -$605
CHCO icon
1817
City Holding Co
CHCO
$2.04B
$11K ﹤0.01%
184
+37
+25% +$2.35K
CLVT icon
1818
Clarivate
CLVT
$1.29B
$11K ﹤0.01%
500
DBEF icon
1819
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.23B
$11K ﹤0.01%
370
-1,214
-77% -$35.2K
DGII icon
1820
Digi International
DGII
$2.57B
$11K ﹤0.01%
997
+277
+38% +$2.96K
DRRX
1821
DELISTED
DURECT Corp
DRRX
$11K ﹤0.01%
500
ENVA icon
1822
Enova International
ENVA
$6.31B
$11K ﹤0.01%
802
+130
+19% +$1.81K
GMS
1823
DELISTED
GMS Inc
GMS
$11K ﹤0.01%
470
-28
-6% -$534
HTLD icon
1824
Heartland Express
HTLD
$986M
$11K ﹤0.01%
537
+350
+187% +$7.03K
ICF icon
1825
iShares Select U.S. REIT ETF
ICF
$2.1B
$11K ﹤0.01%
224
-240
-52% -$11.8K

Similar funds

Glenmede Trust's Q2 2020 Portfolio in Review

As of Q2 2020, Glenmede Trust held 3,458 positions worth $16.4B, down 25% from $21.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Glenmede Trust withdrew a net $3.87B in Q2 2020, closing 907 positions and reducing 1,077 holdings. Its most notable exit was Raytheon Company, an estimated $66.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Glenmede Trust opened a new position in Carrier Global worth $21.3M.

  • Glenmede Trust's largest Q2 2020 buy was Carrier Global: 960,042 shares worth $21.3M.
  • Glenmede Trust added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $97.1M increase.
  • Glenmede Trust's biggest Q2 2020 reduction was Accenture, cutting an estimated $114M.
  • Glenmede Trust fully exited Raytheon Company in Q2 2020, selling an estimated $66.5M.
  • Glenmede Trust's ten largest holdings make up 18% of its $16.4B portfolio in Q2 2020.
  • Glenmede Trust opened 283 new positions and closed 907 in Q2 2020.
  • Glenmede Trust's portfolio value fell 25% quarter-over-quarter to $16.4B.

Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.